» Articles » PMID: 792893

Analgesic Evaluation of Butorphanol in Patients with Postoperative Wound Pain

Overview
Specialty Pharmacology
Date 1976 Jan 1
PMID 792893
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Two agonist/antagonist analgesics, butorphanol tartrate (test) and pentazocine hydrochloride (standard), were compared in volunteer informed patients experiencing postoperative wound pain. The relative potency (p) is 0.04 (1 mg butorphanol equals 24.3 mg of pentazocine lactate) with upper and lower confidence limits of 0.01 and 0.07 respectively. Butorphanol tartrate in the higher dose appears to have longer duration of effect. The side effects were comparable in the population studied.

Citing Articles

The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.

Shyu W, PITTMAN K, Robinson D, Barbhaiya R Eur J Clin Pharmacol. 1993; 45(6):559-62.

PMID: 8157043 DOI: 10.1007/BF00315315.


The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol.

Shyu W, Morgenthien E, PITTMAN K, Barbhaiya R Eur J Clin Pharmacol. 1994; 47(1):57-60.

PMID: 7988625 DOI: 10.1007/BF00193479.


Butorphanol: a review of its pharmacological properties and therapeutic efficacy.

Heel R, Brogden R, Speight T, Avery G Drugs. 1978; 16(6):473-505.

PMID: 365510 DOI: 10.2165/00003495-197816060-00001.